Join our dedicated team

NEWS

ViroSpot MN assay, a novel tool for antigenic characterization of influenza viruses and serology.
The ViroSpot assay platform is currently available for influenza virus and RSV, and under development for multiple other viral targets.
read more

Specialized team of scientists

NEWS

ViroSpot MN assay, a novel tool for antigenic characterization of influenza viruses and serology.
The ViroSpot assay platform is currently available for influenza virus and RSV, and under development for multiple other viral targets.
read more

Virology Contract Research Laboratory

JOB OPPORTUNITIES

Viroclinics Biosciences is a leader in the strongly growing and very dynamic market of diagnostic services companies. As a service organization we offer serological, virus-based and molecular analyses of any type of sample to assist our global customers with testing their antiviral drugs and vaccines. Our analyses encompass many types of viruses, including Influenza, RSV and Polio. Our rapidly growing company is now expanding its HBV Business Unit. 

This expansion is part of our growth strategy and allows for hiring two new key leadership positions: a Director HBV Business Development and a Director HBV Services.

OUR LATEST NEWS

Parcom Capital acquires Viroclinics Biosciences

Parcom Capital has acquired the successful clinical research organisation Viroclinics Biosciences. Viroclinics believes Parcom is the perfect partner to help it realise its growth ambitions.

Viroclinics Biosciences endorsed for GLP compliancy

Viroclinics Biosciences serves as a virology contract research organization in the bio pharmaceutical community with preclinical, clinical diagnostic, assay development and clinical trial logistics services. Especially with extensive experience in clinical and...

↓